Research shows that the Rad51 biomarker allows personalized treatment in early-stage breast cancer
An international study led by researchers from the Vall d'Hebron Institut d'Oncologia (Vhio) from Barcelona has highlighted the potential of ...
An international study led by researchers from the Vall d'Hebron Institut d'Oncologia (Vhio) from Barcelona has highlighted the potential of ...